Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Acoziborole in Paediatric Patients With g-HAT
NCT05433350Phase 3Completed
- Sponsor
- Drugs for Neglected Diseases initiative
- Start
- Jul 2022
- Primary completion
- Mar 2026
- Modality
- Small Molecules
- Countries
- 2
01
Overview
A Phase 3 trial of acoziborole in human African trypanosomiasis (HAT), sponsored by Drugs for Neglected Diseases initiative. Started Jul 2022; status: completed.
02
Drugs
acoziborole
03
Conditions
human African trypanosomiasis (HAT)
Beyond the preview
Go deeper on NCT05433350.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05433350.